tm logo
PREDICTGEN
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 13 Nov 2024

Last Applicant/ Owned by

46701 Commerce Center Drive

Plymouth

MI

48170

Serial Number

97096948 filed on 28th Oct 2021

Registration Number

N/A

Correspondent Address

ROGER H. BORA

ROGER H. BORA THOMPSON HINE LLP

DAYTON, OH 45342-4934

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

PREDICTGEN

Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; scientific and technological services in the field of pharmaceuticals featuring pharmacogenomic testing analysis and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how an individual's genetic and non-genetic factors affect their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; scientific and technological services in the field of pharmaceuticals, namely, scientific testing, research, and analysis for the purpose of determining a patient's disease and drug response phenotype through evaluation of chromatin state, genomic regulatory elements, epigenomics, proteomics, metabolomics, transcriptomics, environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of buccal, saliva, blood and other biological samples for the purposes of supporting drug clinical trials and research into the field of new drug development and drug repurposing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97096948

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Nov 2024SOU EXTENSION 2 FILED
13th Nov 2024SOU EXTENSION 2 GRANTED
13th Nov 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Nov 2024SOU TEAS EXTENSION RECEIVED
11th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10th May 2024SOU EXTENSION 1 GRANTED
10th May 2024SOU TEAS EXTENSION RECEIVED
10th May 2024SOU EXTENSION 1 FILED
14th Nov 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11th Oct 2023EXPARTE APPEAL TERMINATED